Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. - Wikidata - wikimedia - TriplyDB

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

http://www.wikidata.org/entity/Q34182910

about

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene Mutations in ZMYND10, a gene essential for proper axonemal assembly of inner and outer dynein arms in humans and flies, cause primary ciliary dyskinesia WNT7a induces E-cadherin in lung cancer cells A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation Aberrant CBFA2T3B gene promoter methylation in breast tumors DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR.High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.Comparative expression profiling of testis-enriched genes regulated during the development of spermatogonial cells.Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells.Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter.Identifying cancer driver genes in tumor genome sequencing studies.Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma Epigenetics of kidney cancer and bladder cancer.Inactivation of LLC1 gene in nonsmall cell lung cancer Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1 3p21.3 tumor suppressor cluster: prospects for translational applications.Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma.DNA methylation in hepatocellular carcinoma.Epigenetic aberrant methylation of tumor suppressor genes in small cell lung cancer Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma Epigenetic markers in human gliomas: prospects for therapeutic intervention.Study of epigenetic properties of Poly(HexaMethylene Biguanide) hydrochloride (PHMB).Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.Tumor suppressor BLU promotes TRAIL-induced apoptosis by downregulating NF-κB signaling in nasopharyngeal carcinoma.Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation.Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.High-resolution melting analysis of BLU methylation levels in gastric, colorectal, and pancreatic cancers.Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.

P2860

Q24300355-82AD111F-19F5-442C-ACB5-693E32E5B24E Q24312391-DA967F38-AFE4-4777-BCCE-B176D6E3BDCF Q24317695-2A34DB32-208D-4729-8C10-F430F4372940 Q24801375-DACA9D27-32F4-44CE-9445-95509C25F911 Q24804804-216244A9-8F1C-4E0E-969A-3E675C6A9986 Q28386334-35D97EEB-C528-4E18-994D-CC5F7F764865 Q33321068-5D454BB8-F8D3-4A13-9CFF-6427C744B3F4 Q33355806-1F355491-5354-4827-A890-B24B9C042DE5 Q33570597-220C8B69-5E45-412E-9F59-FB277A0969EC Q33705017-DFD65C7D-F5AE-4DE7-AA59-380314D79B1A Q33818726-6A9CE742-355A-4508-B73E-3264BAF4F458 Q34202118-C9457226-498B-4331-89B5-E13470373783 Q34315482-733B126F-E4DE-4687-A6A2-F3FEC87B98B6 Q34480097-7E2BB549-90E7-4427-B740-A13164A74AC0 Q34787876-B3BFEE84-E611-495B-91D7-46EDACE6A1C5 Q35126668-8DB619B1-27C6-478A-AEA2-ED2F363F9FE6 Q35857807-D1E9D94B-5121-4ACC-8195-715A22BD8007 Q35870444-6A6621C0-3AD6-474D-B560-D61189A90592 Q35915669-229D6CDE-938A-4C3E-ACCA-0DC9E05B2B4E Q36429393-035C0A5B-7A21-4905-9B70-00FDE2CCD326 Q36517724-CF4B8009-3956-4542-A6EC-18368BAA9CA7 Q36601451-6B1926F4-A953-4E4C-BE49-0B336794A6E3 Q36785953-BB7C7497-B4B9-462E-9B2F-B6C026CB87A6 Q37113559-EEC7E296-E67E-4464-8A7E-95F31DE792E1 Q37128022-6114E25E-7713-41B8-A801-88F1DF27FC5D Q37183789-4F0A4F1E-18E8-44D1-9317-C4E6E63AF72F Q37301207-992FEE30-6EDE-41BD-BEB2-009603DE7039 Q38967117-CE1A82C9-544F-4992-B306-AF031C4F3D7E Q39130014-8B2B3DC6-24B4-4C1A-BCE3-F27958916649 Q40393121-B841D728-A1E7-469F-A7B4-E96CF81A03A8 Q40412870-A73AFCB8-C80C-4081-8EA8-DBBF514FE1E0 Q40595717-B83CDCA1-F4C1-4934-8B40-4075EBD188BA Q43693636-D2370C2F-8EAD-4617-BC51-5FC65C5088DC Q46650545-3A87D472-5B97-4693-A2B1-E8B48E88C345 Q47103555-6EFB2CB7-D50B-451B-A384-9326FB6DF9B6 Q49544302-EF693A79-4D5D-431F-AB38-88A47D7E9299 Q54302152-676A6767-B133-427D-9E46-7340CDEF04FF Q54329346-826C4421-233C-4A17-840F-65A2D5E684C6 Q55267254-ECA525D0-CD9D-4E03-92BC-A1F10A02F4CB

P2860

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

http://www.wikidata.org/entity/Q34182910

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@ast

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@en

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@nl

type

label

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@ast

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@en

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@nl

prefLabel

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@ast

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@en

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

@nl

P1433

Q34182910-10018923-9167-4BAB-862E-245BAAEEB658

P1476

Q34182910-23846341-49F0-42B8-9A4D-BA05924E2814

P2093

Q34182910-221A9037-D3A1-41D4-937D-C4B9874F3F78

Q34182910-23C5E84B-5DC7-4EC5-9293-9FDE69453423

Q34182910-2774DB6C-0B36-4656-9FF0-BD39B52F0DA4

Q34182910-33F9C3E6-F01B-49E5-BC79-1FCAAC32E49F

Q34182910-38A34302-712A-444E-9310-01C159978251

Q34182910-3A65A023-D2CD-46C6-A4AC-2D550C2C8442

Q34182910-57DF4ADD-216A-4FE1-B7AE-2C53C653D620

Q34182910-968C3C66-25C9-49DA-8B3B-A1209C5BFA8F

Q34182910-B2075188-3B88-4AF1-A3C9-E5AB8F6701ED

Q34182910-BF230377-03B5-4D8D-A164-918D7B7FA87C

P2860

Q34182910-07CAE40B-936D-4FFE-85A1-53171804BC5E

Q34182910-0AC2C02B-3ECA-43AC-934B-99E7ADFD84BF

Q34182910-0EA8AE97-DDB9-4161-B9CD-77744C1B512E

Q34182910-46AA4316-ABCA-439C-AD4F-2810CDB63E0E

Q34182910-65741C98-088D-4F93-982B-181F4ECC90F9

Q34182910-B0C31CF6-60C2-44CE-9005-2D8B6CA83B80

Q34182910-CC0124F0-A25A-467E-A856-B2919CBE4B3C

Q34182910-DA03686D-4CFC-4491-9B21-C20D7331BEB7

Q34182910-E9A46D96-747D-4462-9F65-E614600057F4

P2888

Q34182910-E963FB21-B95C-46FC-A2FF-EC19915DCD16

P304

Q34182910-CA2AECA5-000A-4CC8-84BF-15B5A0609E77

P31

Q34182910-0461BF8D-28E9-4997-B3D0-797D7DC16D9A

P356

Q34182910-6466DC42-A025-4EC8-B2D6-48B03BEB54BA

P407

Q34182910-9D93AE2D-C3D8-4B58-A449-6D46B8EB34AB

P433

Q34182910-EDD9C7B7-409A-443B-99C5-85028F4875E5

P478

Q34182910-574C7FFF-9080-4AE6-B50F-4659F343530B

P50

Q34182910-260DD974-54E9-465E-9FD0-D08D9780D116

Q34182910-358F8781-9191-4934-9AC3-867C809D8673

Q34182910-DB056B5B-FEF6-4970-9F88-F9DDBD882EED

P577

Q34182910-9B6FAA70-048A-463B-90D6-54A7A9F27004

P5875

Q34182910-6C825746-4561-451C-8C88-33E8C5534D6C

P6179

Q34182910-4A3C9647-B34F-471F-8383-EC6EFF2B193C

P698

Q34182910-EB8E6D8B-1CCD-4920-84D1-1120078E5A32

P356

P1433

P1476

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers

@en

P2093

Angelo Agathanggelou

http://www.w3.org/2001/XMLSchema#string

Ashraf Dallol

http://www.w3.org/2001/XMLSchema#string

Catherine Morrissey

http://www.w3.org/2001/XMLSchema#string

Farida Latif

http://www.w3.org/2001/XMLSchema#string

John D Minna

http://www.w3.org/2001/XMLSchema#string

Kwun M Fong

http://www.w3.org/2001/XMLSchema#string

Luke Hesson

http://www.w3.org/2001/XMLSchema#string

Michael J Kuo

http://www.w3.org/2001/XMLSchema#string

Po Wing Yuen

http://www.w3.org/2001/XMLSchema#string

Sofia Honorio

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif

A G-to-A single nucleotide polymorphism in intron 2 of the human CACNA2D2 gene that maps at 3p21.3.

Identification of a single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene.

Von Hippel-Lindau disease: clinical and molecular perspectives.

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

A G-to-A single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene that maps at chromosome 3p21.3.

Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter.

Molecular cloning, sequence analysis, expression, and tissue distribution of suppressin, a novel suppressor of cell cycle entry.

P2888

P304

1580-1588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206243

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Tommy Martinsson

Sabine Zöchbauer-Müller

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10861970

http://www.w3.org/2001/XMLSchema#string

P6179

1008985916

http://www.w3.org/2001/XMLSchema#string

P698

12629521

http://www.w3.org/2001/XMLSchema#string